Table 4.
Adverse events in the study patients (n = 89)
| Event | No. of patients (%) |
|---|---|
| Constipation | 12 (13.5) |
| Local reaction | 2 (2.2) |
| Pruritus | 2 (2.2) |
| Flu-like symptoms | 2 (2.2) |
| Abdominal cramps | 1 (1.1) |
| Transient skin rash | 1 (1.1) |
| Bloating | 1 (1.1) |
| Meteorism | 1 (1.1) |
| Nausea | 1 (1.1) |
| Transient vaginal spotting | 1 (1.1) |
| Urticariaa | 1 (1.1) |
| Vertigo | 1 (1.1) |
| Allergic reactionb | 1 (1.1) |
| Serious adverse events | 1 (1.1) |
| Adverse events leading to treatment discontinuation | 1 (1.1) |
| Total | 20 (22.5) |
aExacerbation of previous disease
bleading to treatment discontinuation